Related Experiment Videos
CSF dopamine-beta-hydroxylase activity in Parkinson's disease
Neurology
|April 1, 1985
Summary
Parkinsonism patients exhibit significantly lower dopamine-beta-hydroxylase (DBH) activity in cerebrospinal fluid, indicating reduced central noradrenergic activity. This suggests potential issues with noradrenergic nerve function or catecholamine synthesis in Parkinson's disease.
Area of Science:
- Neuroscience
- Biochemistry
Background:
- Parkinsonism is primarily linked to dopamine deficiency.
- Norepinephrine levels are also reduced in the central nervous system (CNS) in parkinsonism.
Purpose of the Study:
- To investigate central noradrenergic activity in parkinsonism.
- To measure dopamine-beta-hydroxylase (DBH) activity in the cerebrospinal fluid (CSF) of patients with parkinsonism.
Main Methods:
- CSF samples were collected from previously unmedicated parkinsonian patients and normal controls.
- Dopamine-beta-hydroxylase (DBH) activity was measured as a marker of central noradrenergic activity.
Main Results:
- Parkinsonian patients showed a significant reduction in CSF DBH levels.
- DBH levels in parkinsonian patients were 41% of control values (p < 0.01).
Conclusions:
- The findings suggest diminished central noradrenergic activity in parkinsonism.
- Possible causes include a reduced noradrenergic nerve pool or impaired catecholamine synthesis.